ValiRx PLC VAL

Last Price
0.44
Day Change
-0.01|-2.22%

As of 21/05/2013
16:20:52 BST | GBX  Minimum 15 Minutes Delay.

Bid/OfferDay RangeVolume90d Ave VolMkt Cap
0.00 - 0.000.44 - 0.464,905,819- 7.529
Last Close52 Week RangeP/EYield %ISIN
0.450.31 - 0.83-2.730.00GB00B23N9136

ValiRx Share Price

Total Returns

 Chg (%)  
3yr, 5yr & 10yr performance data is annualised.
ValiRx PLC-1.12 
FTSE 100 TR GBP8.72
 
Financials
Annual
201020112012
more...
Income Statement
Turnover0.180.460.22
Operating Profit-0.46-1.08-2.35
Net Profit0.22-0.93-2.16
Reported EPS0.07-0.10-0.17
Balance Sheet
Current Assets0.921.952.62
Non Current Assets1.582.622.68
Total Assets2.504.575.30
Current Liabilities0.500.140.26
Total Liabilities0.500.140.26
Total Equity2.004.425.04
Cash Flow
Cash From Operations-0.59-1.46-2.13
Change in Net Cash0.141.530.63
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
more...
'Broker Forecasts' provides consensus figures based on several brokers' views
-------
-------

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
more...
20/11/2012PurchaseGerry Desler0.452,222,22210,000.00
20/11/2012PurchaseKevin Alexander0.451,333,3336,000.00
20/11/2012PurchaseDr Satu Vainikka0.452,222,22210,000.00
20/11/2012PurchaseDr George Morris0.452,222,22210,000.00

Company Profile

ValiRx PLC is engaged in the therapeutic and diagnostic research and development. It has undertaken to develop a novel and groundbreaking class of therapeutics based on the unique and proprietary Gene ICE platform and Hypergenomics technology.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

3

Outlook

(27/03/2013) ch - "I look to the future with much confidence"

Next Event 29/05/2013

Next AGM
Ratios
 CompSecMkt
PER (E)-13.3614.26
Div Yld (E)-4.773.59
PEG (E)--0.360.43
ROCE-68.4051.35-0.32
Op Mrgn-1032.8720.37-55.37
EPS Grwth-14.6717.85

Broker Forecasts

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
more...
Directors
more...
ChairmanNick Thorniley
Chief Executive OfficerDr Satu Vainikka
Finance DirectorGerry Desler
Company SecretaryKevin Alexander